In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...
The company also continues to study Descartes-08 in other autoimmune diseases and has plans for a basket trial in pediatric patients.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback